SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, FDA-authorized PCR ...
Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality Results Today, Visby Medical announced two new relationships that will expand national access to the Visby ...
Mumbai: An RTPCR report showing a person as COVID-19 negative cannot be the sole criterion to reject compensation when all other medical reports clearly indicate the infection, the Bombay High Court ...
The main market opportunities in Syndromic Multiplex Diagnostics include the merging of Point of Care Testing and Molecular Diagnostics, which is streamlining frontline test protocols while reducing ...
Danaher (NYSE:DHR) closed 2025 with what management described as a “strong finish” and better-than-expected performance ...
21 天on MSN
ctDNA levels after neoadjuvant therapy may predict breast cancer recurrence better than ...
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer after they received neoadjuvant treatment and surgery predicted ...
Q4 2025 Earnings Call January 28, 2026 8:00 AM ESTCompany ParticipantsJohn Bedford - Vice President of Investor ...
Celebrities endure some of the harshest, most grueling challenges from the playbook of the actual special forces selection process; their goal is not to win votes and face eliminations -- for them it ...
Emerging opportunities in diagnostics include rapid and point-of-care testing, consumer markets, and biomarker development. Immunoassays are expanding due to genetic advances, with multiplex becoming ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
A nulliparous woman in her 40s presented with abdominal pain and dyspnoea during the second trimester of pregnancy.
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the sponsorship of a symposium at the European Hidradenitis Suppurativa Foundation (EHSF) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果